P01.035  Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

Khasraw, M; McDonald, K; Yip, S; Verhaak, RG; Heimberger, AB; Hall, M; Barnes, E; Hovey, E; Ellingson, BM; Lwin, Z

File(s) not publicly available

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

Version 2 2024-06-13, 13:33

Version 1 2020-02-07, 14:05

journal contribution

posted on 2024-06-13, 13:33 authored by M Khasraw, K McDonald, S Yip, RG Verhaak, AB Heimberger, M Hall, E Barnes, E Hovey, BM Ellingson, Z Lwin

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

History

Journal

Neuro-Oncology

Volume

20

Pagination

iii236-iii236

Location

Oxford, Eng.

Publisher DOI

https://doi.org/10.1093/neuonc/noy139.077

ISSN

1522-8517

eISSN

1523-5866

Language

eng

Publication classification

E3 Extract of paper

Issue

suppl_3

Publisher

Oxford University Press

Usage metrics

Keywords

radiotherapy Nivolumab TMZ elderly GBM patients 3209 Neurosciences 3211 Oncology and carcinogenesis

Licence

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

File(s) not publicly available

P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress

History

Journal

Volume

Pagination

Location

Publisher DOI

ISSN

eISSN

Language

Publication classification

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports